Skip to main navigation Skip to search Skip to main content

Assessment of potentially inappropriate prescribing for adults with type 2 diabetes mellitus in Ethiopia using IMPACT2DM, a new explicit tool

  • Mohammed B Ayalew
  • , Gudrun Dieberg (Supervisor)
  • , Frances Quirk (Supervisor)
  • , Joy M Spark (Supervisor)

Research output: Contribution to conferenceAbstract

Abstract

Introduction. People with T2DM are at greater risk of potentially inappropriate prescribing (PIP) due to multiple comorbidities and polypharmacy. IMPACT2DM (Inappropriate Medication Prescribing Assessment Criteria for Type 2 Diabetes Mellitus) is a 70-item tool designed to identify PIP for adults with T2DM.

Original languageEnglish
Pages9-9
Publication statusPublished - 1 Dec 2021
EventAPSA 2021: Australasian Pharmaceutical Science Association Annual Conference - Online Event, Online Event
Duration: 6 Dec 20218 Dec 2021

Conference

ConferenceAPSA 2021: Australasian Pharmaceutical Science Association Annual Conference
CityOnline Event
Period6/12/218/12/21

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Assessment of potentially inappropriate prescribing for adults with type 2 diabetes mellitus in Ethiopia using IMPACT2DM, a new explicit tool'. Together they form a unique fingerprint.

Cite this